|
1
|
Cheah CY, Seymour JF and Wang ML: Mantle
cell lymphoma. J Clin Oncol. 34:1256–1269. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Robak T, Huang H, Jin J, Zhu J, Liu T,
Samoilova O, Pylypenko H, Verhoef G, Siritanaratkul N, Osmanov E,
et al: Bortezomib-based therapy for newly diagnosed mantle-cell
lymphoma. N Engl J Med. 372:944–953. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vose JM: Mantle cell lymphoma: 2013 Update
on diagnosis, risk-stratification, and clinical management. Am J
Hematol. 88:1082–1088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pérez-Galán P, Dreyling M and Wiestner A:
Mantle cell lymphoma: Biology, pathogenesis, and the molecular
basis of treatment in the genomic era. Blood. 117:26–38. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mohanty A, Sandoval N, Das M, Pillai R,
Chen L, Chen RW, Amin HM, Wang M, Marcucci G, Weisenburger DD, et
al: CCND1 mutations increase protein stability and promote
ibrutinib resistance in mantle cell lymphoma. Oncotarget.
7:73558–73572. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dreyling M and Ferrero S; European Mantle
Cell Lymphoma Network, : The role of targeted treatment in mantle
cell lymphoma: Is transplant dead or alive? Haematologica.
101:104–114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Beà S and Amador V: Role of SOX11 and
genetic events cooperating with cyclin D1 in mantle cell lymphoma.
Curr Oncol Rep. 19:432017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lord M, Wasik AM, Christensson B and
Sander B: The utility of mRNA analysis in defining SOX11 expression
levels in mantle cell lymphoma and reactive lymph nodes.
Haematologica. 100:e369–e372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Palomero J, Vegliante MC, Eguileor A,
Rodriguez ML, Balsas P, Martinez D, Campo E and Amador V: SOX11
defines two different subtypes of mantle cell lymphoma through
transcriptional regulation of BCL6. Leukemia. 30:1596–1599. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang G, Liu J, Wang Q, Huang X, Yang R,
Pang Y and Yang M: MicroRNA-223-3p regulates ovarian cancer cell
proliferation and invasion by targeting SOX11 expression. Int J Mol
Sci. 18:12082017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shepherd JH, Uray IP, Mazumdar A,
Tsimelzon A, Savage M, Hilsenbeck SG and Brown PH: The SOX11
transcription factor is a critical regulator of basal-like breast
cancer growth, invasion, and basal-like gene expression.
Oncotarget. 7:13106–13121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Palomero J, Vegliante MC, Rodríguez ML,
Eguileor Á, Castellano G, Planas-Rigol E, Jares P, Ribera-Cortada
I, Cid MC, Campo E and Amador V: SOX11 promotes tumor angiogenesis
through transcriptional regulation of PDGFA in mantle cell
lymphoma. Blood. 124:2235–2247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Balsas P, Palomero J, Eguileor Á,
Rodríguez ML, Vegliante MC, Planas-Rigol E, Sureda-Gómez M, Cid MC,
Campo E and Amador V: SOX11 promotes tumor protective
microenvironment interactions through CXCR4 and FAK regulation in
mantle cell lymphoma. Blood. 130:501–513. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang X, Gee H, Rose B, Lee CS, Clark J,
Elliott M, Gamble JR, Cairns MJ, Harris A, Khoury S and Tran N:
Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in
oropharyngeal cancers. BMC Cancer. 16:862016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Guo Q, Yang P and Long G:
Restoration of microRNA-212 causes a G0/G1 cell cycle arrest and
apoptosis in adult T-cell leukemia/lymphoma cells by repressing
CCND3 expression. J Investig Med. 65:82–87. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ambrosio MR, Mundo L, Gazaneo S,
Picciolini M, Vara PS, Sayed S, Ginori A, Lo Bello G, Del Porro L,
Navari M, et al: MicroRNAs sequencing unveils distinct molecular
subgroups of plasmablastic lymphoma. Oncotarget. 8:107356–107373.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ju C, Zhou R, Sun J, Zhang F, Tang X, Chen
KK, Zhao J, Lan X, Lin S, Zhang Z and Lv XB: LncRNA SNHG5 promotes
the progression of osteosarcoma by sponging the miR-212-3p/SGK3
axis. Cancer Cell Int. 18:1412018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu H, Li C, Shen C, Yin F, Wang K, Liu Y,
Zheng B, Zhang W, Hou X, Chen X, et al: miR-212-3p inhibits
glioblastoma cell proliferation by targeting SGK3. J Neurooncol.
122:431–439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hou P, Kang Y and Luo J: Hypoxia-mediated
miR-212-3p downregulation enhances progression of intrahepatic
cholangiocarcinoma through upregulation of Rab1a. Cancer Biol Ther.
19:984–993. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yuan S, Dong Y, Peng L, Yang M, Niu L, Liu
Z and Xie J: Tumor-associated macrophages affect the biological
behavior of lung adenocarcinoma A549 cells through the PI3K/AKT
signaling pathway. Oncol Lett. 18:1840–1846. 2019.PubMed/NCBI
|
|
23
|
Danilov AV and Persky DO: Incorporating
acalabrutinib, a selective next-generation Bruton tyrosine kinase
inhibitor, into clinical practice for the treatment of
haematological malignancies. Br J Haematol. 193:15–25. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kuo PY, Leshchenko VV, Fazzari MJ, Perumal
D, Gellen T, He T, Iqbal J, Baumgartner-Wennerholm S, Nygren L,
Zhang F, et al: High-resolution chromatin immunoprecipitation
(ChIP) sequencing reveals novel binding targets and prognostic role
for SOX11 in mantle cell lymphoma. Oncogene. 34:1231–1240. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beekman R, Amador V and Campo E: SOX11, a
key oncogenic factor in mantle cell lymphoma. Curr Opin Hematol.
25:299–306. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia L, Li D, Lin C, Ou S, Li X and Pan S:
Comparative study of joint bioinformatics analysis of underlying
potential of ‘neurimmiR’, miR-212-3P/miR-132-3P, being involved in
epilepsy and its emerging role in human cancer. Oncotarget.
8:40668–40682. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Haenisch S, Zhao Y, Chhibber A,
Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK,
Lowenstein DH, Cascorbi I and Kroetz DL: SOX11 identified by target
gene evaluation of miRNAs differentially expressed in focal and
non-focal brain tissue of therapy-resistant epilepsy patients.
Neurobiol Dis. 77:127–140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Z, Jiang S, Lu C, Ji T, Yang W, Li T,
Lv J, Hu W, Yang Y and Jin Z: SOX11: Friend or foe in tumor
prevention and carcinogenesis? Ther Adv Med Oncol.
11:17588359198534492019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yao Z, Sun B, Hong Q, Yan J, Mu D, Li J,
Sheng H and Guo H: The role of tumor suppressor gene SOX11 in
prostate cancer. Tumour Biol. 36:6133–6138. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsang SM, Oliemuller E and Howard BA:
Regulatory roles for SOX11 in development, stem cells and cancer.
Semin Cancer Biol. 67:3–11. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang J, Ji EH, Zhao X, Cui L, Misuno K,
Guo M, Huang Z, Chen X and Hu S: Sox11 promotes head and neck
cancer progression via the regulation of SDCCAG8. J Exp Clin Cancer
Res. 38:1382019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L, Shen YF, Shi ZM, Shang XJ, Jin DL
and Xi F: Overexpression miR-211-5p hinders the proliferation,
migration, and invasion of thyroid tumor cells by downregulating
SOX. J Clin Lab Anal. 32:e222932018. View Article : Google Scholar : PubMed/NCBI
|
